More about

MUSC Storm Eye Institute

News
November 03, 2020
9 min read
Save

Small-aperture optics can improve depth of focus without compromising vision

A pinhole effect, achieved through surgery, pharmacologic agents, IOLs or inlays, can treat significant irregular corneal astigmatism and higher-order aberrations, whose effects are minimized by reducing pupillary aperture.

News
September 22, 2020
3 min read
Save

Pharmaceutical therapies for presbyopia may bridge gap until surgery is needed

Two main classes of pharmaceutical therapies that use different mechanisms of action to treat presbyopia may be effective, noninvasive solutions for patients who are not yet good candidates for surgery.

News
February 13, 2020
6 min read
Save

Roundtable: Corneal consequences of chronic inflammation can be severe in children

Meibomian gland dysfunction is not an adults-only disease, and when the combination of inflammation of the eyelids, conjunctiva and cornea is prolonged in children, the corneal consequences and effect on vision can be severe.

News
July 26, 2016
6 min watch
Save

VIDEO: Speaker talks about improving resident education

At Kiawah Eye, Anne M. Schroeder, MD, discusses how ophthalmologists can improve resident education including exam technique, inpatient pathology and protocol development.

News
May 30, 2014
1 min watch
Save

Smartphone app helps diagnose uveitis, reduce lab costs and testing

KIAWAH ISLAND, S.C. — A new diagnostic app demonstrated high levels of success in accurately diagnosing patients with uveitis, according to a presenter here.

News
May 25, 2008
7 min read
Save

FDA panel scrutinizes LASIK safety data

GAITHERSBURG, Md. – Issues surrounding patient safety, patient satisfaction and even marketing practices associated with LASIK came under intense scrutiny since the U.S. Food and Drug Administration Ophthalmic Devices Panel heard public testimony in April in favor of and sometimes vehemently opposed to the surgery. Jayne S. Weiss, MD, chair of the FDA Ophthalmic Devices Panel, is involved in the FDA’s review of LASIK safety data. Based in part on the testimony and the passage of time since labeling information was last reviewed, the panel made recommendations to update labeling information as well as its own patient information Web site.